Jacobson Pharma Corp
2633
End-of-day quote Stock Exchange of Hong Kong - 09/24
1.88HKD
0%
Prev.1.8800
Open1.8700
High1.8800
Low1.8500
Volume98 000
Financials
Sales 2019 1 749 M
EBIT 2019 361 M
R. net 2019 245 M
Debt 2019 -
Rend. 2019 2,15%
P/E ratio 2019 15,04
P/E ratio 2020 12,97
Capi. / Sales 2019 2,17x
Capi. / Sales 2020 1,96x
Capitalization 3 789 M
Company
Jacobson Pharma Corp. Ltd. engages in the provision of generic drugs for both public and private sectors.It operates through the following segments: Generic Drugs, Proprietary Medicines, and Wholesale and Retal.The Generic Drugs segment develops, manufactures and distributes a host of off-patent...
Sector :
Generic Pharmaceuticals
Calendar :
2018-11-21 Earnings Release
Trading Rating :
Investor Rating :
Latest news
08/25JACOBSON PHARMA : buys Dickson Warehousing's Shatin warehouse
AQ
06/25JACOBSON PHARMA : Announces 2018 Annual Results
AQ
06/20JACOBSON PHARMA CORPORATION LTD : annual earnings release
06/14JACOBSON PHARMA : reveals test results of products
AQ
06/13JACOBSON PHARMA : Updates on TAILORx Study
AQ
04/17JACOBSON PHARMA : Ranked No. 1 in "Hong Kong Best Small-Cap Company" in the "Asia's Best Companies Poll 2018" by FinanceAsia
AQ
2017Jacobson Pharma (02633) to buy stake in Fosun Pharma's unit
AQ
2017JACOBSON PHARMA : Enters Agreements with Shanghai Henlius Biotech Inc. To Tap Biologics Market
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralBearish
Resistance1,972,121,94
Spread/Res.-4,6%-11%-3,1%
Spread/Supp.5,0%9,3%6,8%
Support1,791,721,76